ArticleWorld journal of transplantation2021

Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: A systematic review and meta-analysis.

Boonphiphop Boonpheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.